Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.61
-0.61 (-9.80%)
Nov 15, 2024, 2:13 PM EST - Market open
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for VYGR stock have an average target of 17, with a low estimate of 7.00 and a high estimate of 30. The average target predicts an increase of 203.08% from the current stock price of 5.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VYGR stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +149.59% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +434.85% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +434.85% | Oct 24, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $15 | Buy | Initiates | $15 | +167.42% | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +434.85% | Aug 20, 2024 |
Financial Forecast
Revenue This Year
73.53M
from 250.01M
Decreased by -70.59%
Revenue Next Year
63.89M
from 73.53M
Decreased by -13.11%
EPS This Year
-1.34
from 2.97
EPS Next Year
-1.71
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 103.3M | 155.9M | 154.3M | ||
| Avg | 73.5M | 63.9M | 68.4M | ||
| Low | 53.0M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -58.7% | 112.0% | 141.5% | ||
| Avg | -70.6% | -13.1% | 7.0% | ||
| Low | -78.8% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.56 | -0.51 | -0.35 | ||
| Avg | -1.34 | -1.71 | -1.43 | ||
| Low | -1.67 | -2.90 | -2.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.